Physician profile
Ali Najafi
NPI 1124129473
$43,535.78
in general payments reported to CMS, 2019-2025
15 companies · $948 in 2025
The $948 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $7,807 · 2021: $8,461 · 2022: $8,159 · 2023: $1,905 · 2024: $2,599 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,038 · Royalty Or License: $2,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,038.14 |
| Royalty Or License | $2,414.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $38,645.20 | 2019-2024 | Novel |
| Medtronic, INC. | $3,752.85 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Medtronic USA, INC. | $641.37 | 2019-2020 | |
| Osseus Fusion Systems, LLC | $104.00 | 2019 | |
| Stryker Corporation | $93.67 | 2021 | |
| Boston Scientific Corporation | $77.08 | 2022-2024 | |
| Medline Industries LP | $58.19 | 2019 | |
| Nevro Corp. | $41.19 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $27.32 | 2021 | |
| Aesculap Implant Systems, LLC | $25.54 | 2021 | |
| Spr Therapeutics, INC | $22.23 | 2023 | Sprint Pns System |
| Globus Medical, INC. | $17.48 | 2025 | Senza |
| Abbott Laboratories | $16.93 | 2021 | |
| Relievant Medsystems, INC. | $12.73 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,322,034.61 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Najafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.